Name | Type | Posted | Actions |
|---|---|---|---|
Amend_1_75F40125R00037_QR.pdf | Jun 25, 2025 | ||
Amend_1_75F40125R00037_Attachment 7 - FDA Secure Electronic Mail System.pdf | Jun 25, 2025 | ||
Amend_1_75F40125R00037_Attachment 14 - Task Order Statement of Work.pdf | Jun 25, 2025 | ||
Amend_1_75F40125R00037_Attachment 13 - Pricing Worksheet.xlsx | XLSX | Jun 25, 2025 | |
Amend_1_75F40125R00037.pdf | Jun 25, 2025 | ||
Sol_Doc_75F40125R00037_Attachment 5 - Census Regions.pdf | Jun 2, 2025 | ||
Sol_Doc_75F40125R00037_Attachment 8 - Active FAR - HHSAR Class Deviations.pdf | Jun 2, 2025 | ||
Sol_Doc_75F40125R00037_Attachment 12 - Past Performance Questionnaire.docx | DOCX | Jun 2, 2025 | |
Sol_Doc_75F40125R00037_Attachment 11 - Past Performance Worksheet.docx | DOCX | Jun 2, 2025 | |
Sol_Doc_75F40125R00037_Attachment 10 - Example of Monthly Report.xlsx | XLSX | Jun 2, 2025 | |
Sol_Doc_75F40125R00037_Attachment 9 - HHS Subcontracting Plan.pdf | Jun 2, 2025 | ||
Sol_Doc_75F40125R00037_Attachment 4 - Data Disclosure Clearance Forms.docx | DOCX | Jun 2, 2025 | |
Sol_Doc_75F40125R00037_Attachment 3 - Data Disclosure Clearance Procedures.docx | DOCX | Jun 2, 2025 | |
Sol_Doc_75F40125R00037_Attachment 1 - Data Characteristics Table.pdf | Jun 2, 2025 | ||
Sol_Doc_75F40125R00037.pdf | Jun 2, 2025 | ||
Sol_Doc_75F40125R00037_Attachment 2 - Glossary.pdf | Jun 2, 2025 | ||
Sol_Doc_75F40125R00037_Attachment 13 - Pricing Worksheet.xlsx | XLSX | Jun 2, 2025 | |
Sol_Doc_75F40125R00037_Attachment 7 - FDA Secure Electronic Mail System.pdf | Jun 2, 2025 | ||
Sol_Doc_75F40125R00037_Attachment 14 - Task Order Statement of Work.pdf | Jun 2, 2025 | ||
Sol_Doc_75F40125R00037_Attachment 6 - Trial Subscription Agreement.docx | DOCX | Jun 2, 2025 |
Access to Outpatient Longitudinal Data IDIQ
Access to Outpatient Longitudinal Drug Utilization Data
Contact and place of performance
Noah Wills
Silver Spring, MD
USA
This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance with the format in subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. The solicitation is issued as a request for proposal (RFP) in accordance with...
View moreThe Food and Drug Administration (FDA) Office of Acquisition and Grant Services is soliciting proposals for a multiple-award Indefinite-Delivery Indefinite-Quantity (IDIQ) contract to provide access to outpatient longitudinal data. This procurement is conducted as a combined synopsis/solicitation for commercial products and services under NAICS 541519, Other Computer Related Services, and PSC B529, Special Studies/Analysis - Scientific Data. The government intends to award at least two contracts to offerors representing the best value, with a minimum of one award reserved for a small business concern. Task Order #1 is being solicited concurrently with the IDIQ, and offerors must submit separate proposals for both to remain eligible for award.
The primary place of performance is Silver Spring, Maryland. This requirement is unrestricted, and there is no set-aside designated, though the small business size standard for the primary NAICS code is $34 million or 150 employees. Proposals must be submitted by July 3, 2025, and all offerors are required to maintain an active registration in SAM.gov at the time of submission and award. Recent updates to the solicitation via Amendment 1 include responses to formal questions and a revised pricing worksheet necessitated by changes to the performance periods and values for both the IDIQ and the initial task order.
The solicitation documentation, identified by number 75F40125R00037, includes 20 attachments such as a task order statement of work, pricing worksheets, and guidance on the FDA Secure Electronic Mail System. These materials outline the specific technical requirements for the scientific data analysis and computer-related services required by the agency. All evaluation and award procedures will follow FAR Part 12 in conjunction with FAR Part 15 negotiations. Noah Wills serves as the primary point of contact for this requirement.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.